OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE

Clinical trials for OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE explained in plain language.

Never miss a new study

Get alerted when new OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE trials appear

Sign up with your email to follow new studies for OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug ISM8969 enters first human safety tests

Knowledge-focused Not yet recruiting

This early-stage study tests whether a new oral drug called ISM8969 is safe and how the body processes it. About 100 healthy adults, elderly people, and obese adults at risk for heart disease will receive either the drug or a placebo. The goal is to check for side effects and mea…

Matched conditions: OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE

Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Knowledge-focused

Last updated May 17, 2026 05:36 UTC

OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE

Get alerted when new OBESE ADULT PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE trials appear

New drug ISM8969 enters first human safety tests